Close Menu

NEW YORK – In a weekly call with developers of SARS-CoV-2 diagnostic tests, the US Food and Drug Administration strongly encouraged the off-label use of Emergency Use Authorized tests to detect for the virus in asymptomatic people. The agency also encouraged developers of fully at-home tests to consider ways that results can be reported to local public health departments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.